We are committed to helping pioneer a new era in diagnostic technology, where the results from DNA and RNA-based tests can be obtained in the moment of need, at the point of care.
To keep life moving forward, even as new variants may continue to emerge, COVID-19 testing remains important to ensure appropriate patient management and supports the government’s Test to Treat initiative.
Whether you need an antigen or molecular test, we deliver rapid, accurate testing solutions in a variety of healthcare settings.
With access to lab-quality molecular diagnostics at the point of need, clinicians get timely results for actionable decision making. In the future, our portfolio of point-of-care diagnostic tests will include solutions for multiple infectious disease states in a variety of settings.
Subscribe to our newsletter for information about our products and company updates.
The GenBody COVID-19 Ag Test and the Talis One COVID-19 Test System are for use under Emergency Use Authorization (EUA) only. For In Vitro Diagnostic (IVD) use. For prescription use only. Talis is an authorized distributor of the GenBody COVID-19 Ag test.
© Talis and Talis One are trademarks of Talis Biomedical Corporation. All Rights Reserved.
*Additional testing solutions are currently in development and not available for sale.
